Glenmark’s Ryaltris®- innovative single nasal spray, ready to market in Russia

Our Bureau

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris® Nasal Spray – a novel fixed‐dose combination nasal spray.  This paves the way for commercialization of Ryaltris® in Russia which is expected to be made available to patients in the country […]

Subscribe Now